     |
||||||||||||||||||||
|
|
||||||||||||||||||||
Cancer TestsThere are numerous cancer detection and prevention tests that can be used to detect cancer. Some tests that are considered alternative, or less toxic than other standard conventional tests. Some of these tests are not used by conventional physicians, but you can always ask them to look into the test. It is important to understand that one should not rely on any one test - some tests can result in false positives or negatives. One must take all clinical factors into consideration to back up a diagnosis. Some of the tests you may have when doctors are diagnosing or treating your cancer. You may also be asked to have tests as part of your routine follow up once your treatment is over. Specific cancer tests are CT scan, MRI scan, Ultrasound scan, Bone scan, PET Scan, Bone marrow test, Barium X-ray, Endoscopy, Lymphangiogram, IVU (Intravenous urogram) or IVP (IV pyelogram), Lumbar puncture, Cystoscopy.
 2010-09-03 Diabetes drug metformin can reduce risk of cancer, researchers findBy more than 70 pct. , and results from a small clinical trial in Japan suggest it can reduce rates of colorectal tumors in humans. The National Cancer Institute is now organizing a clinical trial to test the drug in people who smoke, and other trials are testing it against breast and In another report in the Cancer Prevention Research journal, researchers from the Yokohama City University School of Medicine and the National Cancer Center Research Institute in Tokyo gave metformin to 12 nondiabetic patients with what are known as aberrant crypt foci, precursors of colorectal cancer. Metformin reduced the development of lung cancer in mice by more than 70 pct. Clinical trials on humans for lung, breast and prostate cancer are being organized.
2010-09-01 Nationwide Prostate Screenings to Detect Cancer and Help Save Lives -- DENVER /PRNewswire-USNewswire/ --In addition to making available essential screening options for men, PCAW also provides valuable information on research issues key to eliminating this threat. Most recently, data from the 2007 and 2008 PCAW screenings, presented at the 2010 annual meeting of the American Society of Clinical Oncology, helped bring to light the high prevalence of supplement use among American men. 1Given previous research suggesting an association between the use of multivitamins and increased risk of advanced prostate cancer, this data provided crucial insights that will help the research community further investigate the safety and efficacy of supplementation and its correlation with prostate cancer. 1PCAW has also provided an opportunity to test new screening methods, such as urine analyses tests. Nationwide Prostate Screenings to Detect Cancer and Help Save Lives. - Prostate Conditions Education Council Colorado Domestic Policy Not For Profit Health Care and Hospitals Medical Pharmaceuticals
2010-08-31 Dunedin laboratory to do tests for cancer Otago Daily Times Online News Keep Up to Date Local, National New Zealand and International NewsPacific Edge has been working with a partner to develop a test for colorectal cancer, and Mr Darling told shareholders that partner was commercialising a test which over the next nine months would be converted for its own use. Pacific Edge used a process called gene expression microarrays to identify critical genes in certain cancers, which they now test for in patient samples to determine their disease status. Changes to the test will allow Pacific Edge to diagnose how aggressive tumours were in patients with stage two colorectal cancer, to determine appropriate treatment. (image)A laboratory under construction for Pacific Edge Ltd at the University of Otago signals the progression from research to commercial biomedical company. - Business
2010-08-28 Radient Pharmaceuticals Provides Domestic and International Target Market Details for Its Onko-Sure(R) IVD Cancer Diagnostic Test - MarketWatchUS FDA approved use as a CRC Monitoring Test Market in the US and Canada: This market represents a US usd. 200 million per year market at the wholesale level, and is growing at a 10 pct. annual growth rate. The competing test for Onko-Sure(R) is the Carcinoembryonic Antigen (CEA) -- a test that typically only identifies cancer its latest stages when the probability of treating the disease is lowest. Onko-Sure(R) has been clinically shown to identify cancer in its earliest stages, and these studies also indicate Onko-Sure(R) to be a superior test to CEA. To capitalize on this, we are implementing an aggressive commercialization strategy in the US specifically targeted towards physicians, oncologists, clinicians, consumers, patients and reference labs that show demand for the test. - RPC Radient Pharmaceuticals Corp
2010-08-27 Initial Trials on New Ovarian Cancer Test - GLG NewsScientists at the Georgia Institute of Technology have attained very promising results on their initial investigations of a new test for ovarian cancer. Using a new technique involving mass spectrometry of a single drop of blood serum, the test correctly identified women with ovarian cancer in 100 percent of the patients tested. The results can be found online in the journal Cancer Epidemiology, Biomarkers, and Prevention Research. Scientists at the Georgia Institute of Technology have attained very promising results on their initial investigations of a new test for ovarian cancer. Using a new technique involving mass spectrometry of a single drop of blood serum, the test correctly identified women with ovarian cancer in 100 percent of the patients tested. Scientists at the Georgia Institute of Technology have attained very promising results on their initial investigations of a new test for ovarian cancer. Using a new technique involving mass spectro - Laboratory Operations DGX:NYSE Ken Powell Economic Experts on Managed Care Medical Device Experts Healthcare
2010-08-26 Sherrod wont return to USDAShe initially received the news alone, not long after her husband had left the hospital. A doctor apologized for the previous battery of tests failing to detect the cancer. A painful bone marrow aspiration test was required to pinpoint Kevin Skellys condition. And ldquo;Some people regret having cancer and some people wish they never had it, and rdquo; Kelly Skelly said. and ldquo;I always tell Kevin it and rsquo;s the best thing that ever happened to me, because of the friends that I and rsquo;ve made and the friends that I and rsquo;ve lost to the disease. And I met him. and rdquo; Shirley Sherrod wont return to work for the U. S. Department of Agriculture. The former Georgia director for rural development told reporters Tuesday morning that she came very close to taking the new job Agriculture Secretary Tom Vilsack offered her after demanding her resignation more than a month ago. - Sherrod wont return USDA News AJC Georgia Nation TopNews
2010-08-22 Georgia Tech Team Claims 100 Percent Accuracy for Metabolomic Ovarian Cancer Test in Initial Trial ProteoMonitor Proteomics GenomeWebAlthough additional, larger trials are required to validate the test, the initial results suggest it could be useful in screening high-risk patients for ovarian cancer and possibly even as a screening diagnostic for the general population, John McDonald, chief research scientist at Atlantas Ovarian Cancer Institute and one of the papers authors, told There is need, therefore, for diagnostics capable of detecting ovarian cancer in its early stages, and the disease has been a primary focus of diagnostic development, with a variety of protein biomarker-based tests including Vermillions OVA1, Correlogics OvaCheck, Healthlinxs OvPlex, and Arrayits OvaDx in some stage of commercialization.
2010-08-17 New test may help screen for lung cancer The Indianapolis StarWe are in the process of working out those numbers. If theres a lung cancer, 40 percent of the time it will detect it. If we do the test and its positive, theres a 90 percent chance its cancer, so we can skip a lot of testing and go directly to what we need to do for lung cancer. A new blood test, OncImmune, however, helps to answer that question and can save someone a more invasive procedure. Dr. Richard K. Freeman, medical director of oncology services at St. Vincent Hospital, is one of about 400 doctors nationwide who offer the test. New test may help screen for lung cancer - Indianapolis Indiana Indianapolis newspaper The Indianapolis Star newspaper lifestyle living health and fitness shari rudavsky Indianapolis Indiana Indianapolis newspaper The
2010-08-16 Outrage After Error in Screening Breast CancerMore than 1600 women have taken test at the Cumberland Infirmary in Carlisle since with 130 of them being recalled to undergo the test for a second time. So far over 49 women have taken the test for a second time with eight of them testing positive for breast cancer with experts suggesting that the number would rise further. Breast cancer, as the name suggests, is a cancer that affects the breasts or mammary glands. It is the second most popular cancer after lung cancer and is the fifth most common cause of cancer deaths world wide. An error in the breast cancer screening service was found in a hospital in the Carlisle after it was revealed that eight women were given all clear - Breast cancer error daily health news news for the day dental news pharma news medical breakthroughs daily news health topic news
2010-08-13 Breath Test to Detect Lung Cancer a PossibilityResearchers in Israel have developed an "electronic nose" - that is, an instrument that can "smell" the breath of individuals who are healthy or have cancer, and know the difference. They found that the test could not only detect cancer, but could tell the difference between 4 different types of cancer, those being cancers of the lung, breast, colon, and prostate. Early. I cant say how many conversations I have drifted away from - listening to those who have "found" other types of cancer in the early curable stages - while longing for a day when a similar test will be available to find lung cancer. Breath Test to Detect Lung Cancer a Possibility - Breath Test to Detect Lung Cancer a Possibility
|
|
|||||||||||||||||||
|
||||||||||||||||||||
